Quan X. Zhao
Yantai, 264000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Journal: Human vaccines & immunotherapeutics
Published: August 22, 2026
Development and pilot evaluation of an electronic trigger-based surveillance model for sedative-hypnotic drug misuse in a tertiary hospital.
Journal: Scientific reports
Published: April 27, 2026
From molecular mechanisms to digital surveillance: the 2010-2025 evolution of benzodiazepine and Z-drug misuse research.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 06, 2026
Research progress and future prospects of antibacterial drug-loaded bone cement in the treatment of orthopedic infections.
Journal: Journal of orthopaedic surgery and research
Published: March 27, 2026
Economic evaluation of sodium-glucose transporter 2 inhibitors compared with glucagon-like peptide 1 receptor agonist for the treatment of type 2 diabetes: a systematic review.
Journal: European journal of clinical pharmacology
Published: November 27, 2025
Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review.
Journal: Frontiers in health services
Published: August 22, 2025
Efficacy and safety of intravenous iron supplementation for perioperative iron deficiency anemia: a systematic review and network meta-analysis of randomized controlled trials.
Journal: Journal of clinical anesthesia
Published: June 11, 2025
Economic evaluation of liraglutide vs dulaglutide or oral semaglutide in patients with type 2 diabetes mellitus: a systematic review.
Journal: Diabetology & metabolic syndrome
Published: February 20, 2025
Cost-utility analysis of empagliflozin compared with dapagliflozin in patients with type 2 diabetes in China.
Journal: Frontiers in public health
Published: January 24, 2025
Dupilumab induced ocular surface diseases: an analysis of FAERS database, literature review and disease-gene interaction networks.
Journal: Expert opinion on drug safety
Published: January 02, 2025
Cost-effectiveness of benmelstobart and anlotinib plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer in China.
Journal: Scientific reports
Published: August 15, 2024
Last Updated: 09/26/2026